Terry Day to Adult
This is a "connection" page, showing publications Terry Day has written about Adult.
Connection Strength
0.899
-
Intraoperative vasopressors in head and neck free flap reconstruction. Microsurgery. 2021 Jan; 41(1):5-13.
Score: 0.052
-
Evaluation of a survivorship needs assessment planning tool for head and neck cancer survivor-caregiver dyads. J Cancer Surviv. 2019 02; 13(1):117-129.
Score: 0.046
-
Comparison of psychosocial factors over time among HPV+ oropharyngeal cancer and tobacco-related oral cavity cancer patients. Am J Otolaryngol. 2019 Jan - Feb; 40(1):40-45.
Score: 0.045
-
Outcomes and prognostic factors for parotid acinic cell Carcinoma: A National Cancer Database study of 2362 cases. Oral Oncol. 2018 07; 82:53-60.
Score: 0.044
-
Predictors of contralateral-bilateral nodal disease in oropharyngeal cancer: A National Cancer Data Base Study. Head Neck. 2018 02; 40(2):338-348.
Score: 0.042
-
Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer. Cancer. 2017 Dec 15; 123(24):4841-4850.
Score: 0.042
-
Clinical features of ectomesenchymal chondromyxoid tumors: A systematic review of the literature. Oral Oncol. 2017 04; 67:192-197.
Score: 0.040
-
Predictors of survival in parotid adenocarcinoma not otherwise specified: a National Cancer Database study of 3155 patients. Head Neck. 2016 08; 38(8):1208-12.
Score: 0.038
-
Intraoperative goal-directed hemodynamic management in free tissue transfer for head and neck cancer. Head Neck. 2016 04; 38 Suppl 1:E1974-80.
Score: 0.037
-
Lymphoepithelial carcinoma of the major salivary glands: Predictors of survival in a non-endemic region. Oral Oncol. 2016 Jan; 52:24-9.
Score: 0.037
-
Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014 May; 140(5):441-7.
Score: 0.033
-
A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014 Apr; 140(4):331-7.
Score: 0.033
-
The association between T-stage and clinical nodal metastasis In HPV-positive oropharyngeal cancer. Am J Otolaryngol. 2014 Jul-Aug; 35(4):463-8.
Score: 0.032
-
Oral cancer preventive practices of South Carolina dentists and physicians. J Cancer Educ. 2010 Jun; 25(2):166-73.
Score: 0.025
-
Head and neck cancer recurrence and mortality in nonselective cyclooxygenase inhibitor users. Arch Otolaryngol Head Neck Surg. 2007 Jan; 133(1):28-31.
Score: 0.020
-
The use of temporal polyethylene implant after temporalis myofascial flap transposition: clinical and radiographic results from its use in 21 patients. J Oral Maxillofac Surg. 2006 Jan; 64(1):12-22.
Score: 0.019
-
Assessing oral cancer knowledge among dental students in South Carolina. J Am Dent Assoc. 2005 Mar; 136(3):373-8.
Score: 0.018
-
Management of paranasal sinus malignancy. Curr Treat Options Oncol. 2005 Jan; 6(1):3-18.
Score: 0.017
-
Oral cancer knowledge and experience: a survey of South Carolina medical students in 2002. J Cancer Educ. 2005; 20(3):136-42.
Score: 0.017
-
Systematic review of neuroendocrine carcinomas of the oropharynx. Head Neck. 2022 07; 44(7):1725-1736.
Score: 0.014
-
A 2020 Update on Public Awareness of Head and Neck Cancers. Otolaryngol Head Neck Surg. 2022 02; 166(2):305-312.
Score: 0.013
-
Validation of a Novel, Multidomain Head and Neck Cancer Appearance- and Function-Distress Patient-Reported Outcome Measure. Otolaryngol Head Neck Surg. 2020 11; 163(5):979-985.
Score: 0.013
-
Evaluation of a novel telemedicine-based intervention to manage body image disturbance in head and neck cancer survivors. Psychooncology. 2020 12; 29(12):1988-1994.
Score: 0.013
-
Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2020 05 01; 146(5):455-464.
Score: 0.013
-
Association of Medicaid Expansion Under the Affordable Care Act With Stage at Diagnosis and Time to Treatment Initiation for Patients With Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2020 03 01; 146(3):247-255.
Score: 0.012
-
Prognostic factors associated with achieving total oral diet following osteocutaneous microvascular free tissue transfer reconstruction of the oral cavity. Oral Oncol. 2019 11; 98:1-7.
Score: 0.012
-
Body Image Disturbance in Surgically Treated Head and Neck Cancer Patients: A Patient-Centered Approach. Otolaryngol Head Neck Surg. 2019 08; 161(2):278-287.
Score: 0.012
-
Prognostic factors associated with achieving total oral diet after glossectomy with microvascular free tissue transfer reconstruction. Oral Oncol. 2019 05; 92:59-66.
Score: 0.012
-
Association of Care Processes With Timely, Equitable Postoperative Radiotherapy in Patients With Surgically Treated Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2018 12 01; 144(12):1105-1114.
Score: 0.011
-
Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival. Cancer. 2018 08 01; 124(15):3181-3191.
Score: 0.011
-
Thirty-day readmission in patients undergoing head and neck microvascular reconstruction. Head Neck. 2018 07; 40(7):1366-1374.
Score: 0.011
-
Extracapsular Dissection vs Superficial Parotidectomy of Benign Parotid Lesions: Surgical Outcomes and Cost-effectiveness Analysis. JAMA Otolaryngol Head Neck Surg. 2017 11 01; 143(11):1092-1097.
Score: 0.011
-
Prognostic factors and occult nodal disease in mucoepidermoid carcinoma of the oral cavity and oropharynx: An analysis of the National Cancer Database. Oral Oncol. 2017 09; 72:174-178.
Score: 0.010
-
Physical and emotional well-being and support in newly diagnosed head and neck cancer patient-caregiver dyads. J Psychosoc Oncol. 2017 Nov-Dec; 35(6):646-665.
Score: 0.010
-
Perioperative survival of elderly head and neck squamous cell carcinoma patients. Laryngoscope. 2014 Oct; 124(10):2281-6.
Score: 0.008
-
Thyroid disease and compressive symptoms. Laryngoscope. 2012 Jan; 122(1):13-6.
Score: 0.007
-
Neural outcomes after plasma knife dissection: a pathologic study and clinical correlation. Head Neck. 2010 Oct; 32(10):1321-7.
Score: 0.006
-
Respiratory-swallow phase patterns and their relationship to swallowing impairment in patients treated for oropharyngeal cancer. Head Neck. 2010 Apr; 32(4):481-9.
Score: 0.006
-
Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer. Laryngoscope. 2010 Feb; 120(2):236-42.
Score: 0.006
-
Effectiveness of calcium hydroxylapatite paste in vocal rehabilitation. Ann Otol Rhinol Laryngol. 2009 Aug; 118(8):546-51.
Score: 0.006
-
1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells. Otolaryngol Head Neck Surg. 2009 Feb; 140(2):235-40.
Score: 0.006
-
Human papillomavirus and head and neck cancer: a growing concern. J S C Med Assoc. 2008 Dec; 104(8):247-51.
Score: 0.006
-
Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys. 2009 Apr 01; 73(5):1313-8.
Score: 0.006
-
Effect of body mass index on chemoradiation outcomes in head and neck cancer. Laryngoscope. 2008 Jul; 118(7):1180-5.
Score: 0.006
-
Radiation dose, driving performance, and cognitive function in patients with head and neck cancer. Radiother Oncol. 2008 May; 87(2):304-7.
Score: 0.005
-
Driving performance in patients with cancer in the head and neck region: a pilot study. Arch Otolaryngol Head Neck Surg. 2007 Sep; 133(9):904-9.
Score: 0.005
-
Driving behaviors in patients with head and neck cancer during and after cancer treatment: a preliminary report. Head Neck. 2007 Jul; 29(7):675-81.
Score: 0.005
-
Muscle-sparing abdominal free flaps in head and neck reconstruction. Head Neck. 2006 Sep; 28(9):802-7.
Score: 0.005
-
Use of P-32 in stage III epithelial carcinoma of the ovary. Gynecol Oncol. 1994 Jul; 54(1):35-9.
Score: 0.002